Related Experiment Video
Updated: Oct 15, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Local Renin-Angiotensin System Signaling Mediates Cellular Function of Aortic Valves
Asya Ozkizilcik1, Fah Sysavanh1, Smit Patel1
1Department of Biomedical Engineering, University of Arkansas, 122 John A.White Jr. Engineering Hall, Fayetteville, AR, 72701, USA.
The renin-angiotensin system (RAS) activates in aortic valve disease. Researchers used a novel valve thin film (vTF) platform to show RAS mediators impact valve interstitial cell (VIC) contractility, suggesting new drug screening possibilities.
Area of Science:
- Cardiovascular Biology
- Biomaterials Science
- Cellular Physiology
Background:
- The renin-angiotensin system (RAS) is implicated in aortic valve disease pathogenesis.
- The specific functional effects of RAS mediators on valve interstitial cells (VICs) remain largely uncharacterized.
Purpose of the Study:
- To investigate the role of RAS mediators and inhibitors in regulating VIC contractility.
- To develop and utilize a novel gelatin-based valve thin film (vTF) platform for studying VIC function.
Main Methods:
- VICs were cultured under quiescent, activated, and osteogenic conditions on gelatin vTF.
- Cell phenotype, morphology, and contractility were assessed.
- VICs were treated with angiotensin I, angiotensin II, ACE inhibitors, and AT1R inhibitors.
Main Results:
- Anisotropic VIC alignment on vTF was achieved irrespective of culture conditions.
- VICs in activated and osteogenic media exhibited enhanced elongation and increased α-SMA expression.
- Angiotensin I and Ang II dose-dependently increased VIC contractile stress.
- ACE and AT1R inhibitors significantly reduced VIC contraction.
Conclusions:
- A local RAS is active within VICs, influencing their contractile function.
- The developed vTF platform is a promising tool for screening drugs targeting valve disease.
- These findings offer insights into potential therapeutic strategies for aortic valve disease.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Endocrine Signaling
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Hormonal Regulation

